 |
Treatment Algorithms Articles
Textbooks
Clinical Trials
Laboratory Research
Publications
Immunology Fellowship
List of Specialists
Low Vision Instructions
|
 |
 |
Home | News
| Links | How to Help
| Contact Us | Search
Medical Professionals: Laboratory Research:
Fibronectin
C. Stephen Foster, M.D.
Fibronectin (previously known as cold insoluble
globulin) is a plasma protein with multiple functions, but with
most notably facilitation of cell-cell and cell-matrix
interactions. The first report of its presence in the eye was in
1984. Not all species express fibronectin at the epithelial
basement membrane zone, but all have the appearance of
fibronectin on the denuded surface of the cornea after corneal
wounding. We wondered whether or not this suggested that
fibronectin was an essential element for epithelial migration
across the surface of the wounded cornea, and whether or not
exogenously added fibronectin might enhance the speed of wound
healing after corneal wounding. Initial uncontrolled,
non-randomized clinical studies suggested that this might be so.
But, as is so often the case with unmasked, uncontrolled studies
by the paucity of such individuals. But our work suggests, that
rather than any single molecule, a "cocktail" might be
the most effective strategy in encouraging closure of the
epithelium over the wounded cornea. Such a "cocktail"
might include cellular fibronectin, epidermal growth factor,
fibroblast growth factor, insulin-like growth factors,
collagenase inhibitors, and perhaps even corticosteroid.
The sad truth is that there seems to be no magic elixir which is
clinically useful in achieving the goal of getting persistent or
recurrent epithelial defects to close and to stay closed in
patients with ocular surface disease. We have now abandoned our
hope of discovering such a "recipe" and now find
ourselves primarily dependent on tarsorrhaphy for patients with
an anesthetic corneas, and amniotic membrane grafting with or
without limbal stem cell grafting and fitting of scleral lenses
with specialized chambers behind them to retain fluid in patients
with limbal stem cell deficiency and/or extremely poor
subepithelial substrate or basement membrane secondary to various
forms of corneal trauma and ocular surface disease.
REFERENCES:
1. Fujikawa LS, Foster CS, Gipson IK, Colvin RB. 1984. Basement
Membrane Components in Healing Rabbit Corneal Epithelial Wounds:
Immunofluorescence and Ultrastructural Studies. J Cell Biol
98:128-138.
2. Singh G, Foster CS. 1988. Treatment of Nonhealing Corneal
Ulcers and Recurrent Corneal Erosions. The Cornea: Transactions
of the World Congress on the Cornea III, (Ed. Cavanagh HD) Raven
Press, NY. pp. 45-53.
3. Singh G, Foster CS. 1989. Growth Factors in Treatment of
Nonhealing Corneal Ulcers and Recurrent Erosions. Cornea.
8(1):45-53.
4. Phan T-MM, Foster CS, Wasson PJ, Fujikawa LS, Zagachin LM,
Colvin RB. 1989. Role of Fibronectin and Fibrinogen in Healing of
Corneal Epithelial Scrape Wounds. Invest. Ophthalmol. Vis. Sci.
30(3):377-385.
5. Phan T-MM, Foster CS, Zagachin LM, Colvin RB. 1989. Role of
Fibronectin in the Healing of Superficial Keratectomies In Vitro.
Invest. Ophthalmol. Vis. Sci. 30(3):386-391.
6. Phan T-MM, Foster CS, Boruchoff SA, Zagachin LM, Colvin RB.
1987. Topical Fibronectin in the Treatment of Persistent Corneal
Epithelial Defects and Trophic Ulcers. Am. J. Ophthalmol.
104:494-501.
|